openPR Logo
Press release

Roxatidine Market to boost its value by year 2023 : Allied Market Research

02-11-2019 02:31 PM CET | Health & Medicine

Press release from: Allied Market Research

Roxatidine Market

Roxatidine Market

Roxatidine is a special H2-receptor antagonist, which is mostly prescribed for reflux esophagitis, benign gastric ulcer, duodenal ulcer, and prophylaxis of recurrent ulcers. It is generally classified as an antacid, anti-reflux, or anti-ulcerant drug.

The increase in prevalence of people suffering from ulcers, low cost of the drug, and its ability to lower the acid production in the stomach is expected to increase the demand for the drug. However, certain side-effects of the drug such as chest pain, impotence, increased level of lipid in the blood, and gastrointestinal disturbances restraints the market growth.

Send Enquiry on this report @ https://www.alliedmarketresearch.com/purchase-enquiry/4052

The global roxatidine market is segmented based on formulation, application, and region. Based on formulation, it is bifurcated into oral and injectable. Based on application, it is categorized into acidity, heartburn, intestinal ulcers, stomach ulcers, and others. By region, the market is analyzed across North America, Europe, Asia-Pacific, and LAMEA.

The key players operating in this market include Sanofi, Sun Pharmaceutical Industries Ltd., Sihuan Pharmaceutical Holdings Group Ltd., Cayman Chemical, A S Joshi & Company, Taj Pharmaceuticals Limited, and Amgen Inc.

Key Benefits

• The study provides an in-depth analysis of the market with current trends and future estimations to elucidate the imminent investment pockets.
• The report provides information about the current and upcoming trends in the market from 2016 to 2023, which helps determine the prevailing opportunities.
• Comprehensive analysis of factors that drive and restrict the growth of the market is provided.
• Identification of factors instrumental in changing the market scenario, rise in opportunities, and identification of key companies that can influence the market on a global and regional scale are provided.
• Key market players are profiled and their strategies are analyzed thoroughly, which help to understand the competitive outlook of the global market.

Roxatidine Market Key Segments:

By Formulation

• Oral
• Injectable

By Application

• Acidity
• Heartburn
• Intestinal Ulcers
• Stomach Ulcers
• Others

For More Info Visit @ https://www.alliedmarketresearch.com/request-toc-and-sample/4052

About us

Allied Market Research, a market research and advisory company of Allied Analytics LLP, provides business insights and market research reports to large as well as small & medium enterprises. The company assists its clients to strategize business policies and achieve sustainable growth in their respective market domain.

Allied Market Research provides one stop solution from the beginning of data collection to investment advice. The analysts at Allied Market Research dig out factors that help clients to understand the significance and impact of market dynamics. The company amplies client’s insight on the factors, such as strategies, future estimations, growth or fall forecasting, opportunity analysis, and consumer surveys among others. As follows, the company offers consistent business intelligent support to aid the clients to turn into prominent business firm.

Contact:

David Correa
5933 NE Win Sivers Drive
#205, Portland, OR 97220
United States
Toll Free (USA/Canada):
+1-800-792-5285, +1-503-894-6022, +1-503-446-1141
UK: +44-845-528-1300
Hong Kong: +852-301-84916
India (Pune): +91-20-66346060
Fax: +1(855)550-5975
help@alliedmarketresearch.com
Web: https://www.alliedmarketresearch.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Roxatidine Market to boost its value by year 2023 : Allied Market Research here

News-ID: 1577483 • Views:

More Releases from Allied Market Research

L-Lysine Monohydrochloride Global Market Report 2023 - By Demand, Size, Share, Drivers, Trends, Forecast To 2032
L-Lysine Monohydrochloride Global Market Report 2023 - By Demand, Size, Share, D …
Allied Market Research recently released a report titled "L-Lysine Monohydrochloride Market By End-Use Industry (Animal Nutrition, Pharmaceutical, Food and Beverage, Personal Care And Cosmetics, Others): Global Opportunity Analysis and Industry Forecast, 2023-2032". The report indicates that the global L-lysine monohydrochloride industry generated $1.6 billion in 2018 and is expected to reach $3.3 billion by 2032, with a projected Compound Annual Growth Rate (CAGR) of 5.7% from 2023 to 2032. Lysine, primarily
Team Collaboration Software Market Key Futuristic Top Trends and Competitive Landscape by 2027 | Google LLC, IBM Corporation, MindMeld Inc
Team Collaboration Software Market Key Futuristic Top Trends and Competitive Lan …
The team collaboration software industry size was valued at $9,878 million in 2019, and is projected to reach $26,493 million by 2027, growing at a CAGR of 13.2% from 2020 to 2027. COVID-19 has proliferated high adoption of team collaboration software among SMEs at a significant rate. Moreover, imposed work-from-home policies have boosted the adoption of team collaboration software among industries across the globe in 2019. Asia-Pacific being the IT hub
Carnitine Supplements Market: Fueling Health and Wellness with Growing Consumer Demand
Carnitine Supplements Market: Fueling Health and Wellness with Growing Consumer …
According to a new report published by Allied Market Research titled "Carnitine Supplements Market," The carnitine supplements market was valued at $194.50 million in 2021 and is estimated to reach $316.5 million by 2031, growing at a CAGR of 5.1% from 2022 to 2031. 📍Request Sample Report : https://www.alliedmarketresearch.com/request-sample/A31623 The global market for carnitine supplements is anticipated to witness significant growth, driven primarily by the increasing prevalence of excessive weight gain and
Packaged Soup Market: Surge in Convenience Food Demand Propels Growth Amidst Pandemic Challenges
Packaged Soup Market: Surge in Convenience Food Demand Propels Growth Amidst Pan …
"Packaged Soup Market by Product Type (Dried and Wet), End User (Commercial Sector and Household Sector), Packaging (Bottles, Canned and Packets), and Distribution Channel (Supermarket/Hypermarket, Online Store, Convenience Store, Food Service and Others): Global Opportunity Analysis and Industry Forecast, 2021-2027".As per the report, the global packaged soup industry was pegged at $11.75 billion in 2019 and is projected to reach $18.31 billion by 2027, growing at a CAGR of 6.3%

All 5 Releases


More Releases for Roxatidine

PTP Servers Market Trend and Set for Robust Growth During 2021-2027 & Covid-19 A …
Precise details related to market performance is discussed in this PTP Servers market report. It covers insights into sales effectiveness, regulatory scenarios, industry convergence, digital transformation, innovation and competitive landscape. Doing regular basis tracking of business performance is easy under the guidance of this market report. This market analysis also looks over all of the crucial potentials from business players, end purchaser and manufacturers. It further does the market classifications
Informative Report On (COVID-19 Updates) Roxatidine Market, Business Will Grow i …
According to a new report published by Allied Market Research, titled, "Roxatidine Market by Formulation (Oral and Injectable), and by Application (Acidity, Heartburn, Intestinal Ulcers, and Stomach Ulcers) - Global Opportunity Analysis and Industry Forecast, 2020-2027" The report has offered an all-inclusive analysis of the global Roxatidine Market taking into consideration all the crucial aspects like growth factors, constraints, market developments, top investment pockets, future prospects, and trends. At the
Roxatidine Market 2020: Top Companies Analysis To Grow Healthcare Business by 20 …
Business Industry Reports Research has recently announced a report on Global Roxatidine Market based on the Category Industry. The Roxatidine Market report emphasizes various key aspects, which include growth drivers, restraints, opportunities and recent market trends for the forecast period 2020-2024. Global Roxatidine Market overview: Business Industry Reports Analyst covers the Major Players data, including: shipment, revenue, gross profit, interview record, business distribution etc., these data help the consumer know about the
Impact of COVID-19 Outbreak on Roxatidine Market 2020| Worldwide Industry Share, …
Complete study of the global Roxatidine market is carried out by the analysts in this report, taking into consideration key factors like drivers, challenges, recent trends, opportunities, advancements, and competitive landscape. This report offers a clear understanding of the present as well as future scenario of the global Roxatidine industry. Research techniques like PESTLE and Porter's Five Forces analysis have been deployed by the researchers. They have also provided accurate
Roxatidine Market High trend Opportunities offers Future Business Growth by 2027 …
Roxatidine Market 2020-2027: According to a new report published by Allied Market Research, titled, "Roxatidine Market by Formulation (Oral and Injectable), and by Application (Acidity, Heartburn, Intestinal Ulcers, and Stomach Ulcers) - Global Opportunity Analysis and Industry Forecast, 2020-2027" Roxatidine is a special H2-receptor antagonist, which is mostly prescribed for reflux esophagitis, benign gastric ulcer, duodenal ulcer, and prophylaxis of recurrent ulcers. It is generally classified as an antacid, anti-reflux, or
Roxatidine Market to show Rapid Growth During 2017-2023 : Allied Market Research
Roxatidine is a special H2-receptor antagonist, which is mostly prescribed for reflux esophagitis, benign gastric ulcer, duodenal ulcer, and prophylaxis of recurrent ulcers. It is generally classified as an antacid, anti-reflux, or anti-ulcerant drug. The increase in prevalence of people suffering from ulcers, low cost of the drug, and its ability to lower the acid production in the stomach is expected to increase the demand for the drug. However, certain side-effects